134 related articles for article (PubMed ID: 32891476)
21. HPV vaccination: are we initiating too late?
Hofstetter AM; Stockwell MS; Al-Husayni N; Ompad D; Natarajan K; Rosenthal SL; Soren K
Vaccine; 2014 Apr; 32(17):1939-45. PubMed ID: 24530404
[TBL] [Abstract][Full Text] [Related]
22. The Use of Medical Claims Data for Identifying Missed Opportunities for HPV Immunization Among Privately Insured Adolescents in the State of Iowa.
Ryan G; Ashida S; Gilbert PA; Scherer A; Charlton ME; Kahl A; Askelson N
J Community Health; 2022 Oct; 47(5):783-789. PubMed ID: 35715576
[TBL] [Abstract][Full Text] [Related]
23. A quality improvement education initiative to increase adolescent human papillomavirus (HPV) vaccine completion rates.
Bonville CA; Domachowske JB; Suryadevara M
Hum Vaccin Immunother; 2019; 15(7-8):1570-1576. PubMed ID: 31166137
[TBL] [Abstract][Full Text] [Related]
24. Missed opportunities for human papillomavirus vaccination at office visits during which influenza vaccine was administered: An AAP pediatric research in office settings (PROS) national primary care research network study.
Kelly MK; Grundmeier RW; Stephens-Shields AJ; Localio R; Shone LP; Wright M; Steffes J; Humiston SG; Rand C; Albertin C; Breck A; Abney DE; McFarland G; Szilagyi PG; Fiks AG
Vaccine; 2020 Jul; 38(33):5105-5108. PubMed ID: 32540274
[TBL] [Abstract][Full Text] [Related]
25. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study.
Perkins RB; Clark JA; Apte G; Vercruysse JL; Sumner JJ; Wall-Haas CL; Rosenquist AW; Pierre-Joseph N
Pediatrics; 2014 Sep; 134(3):e666-74. PubMed ID: 25136036
[TBL] [Abstract][Full Text] [Related]
26. A stepped-wedge cluster randomized trial designed to improve completion of HPV vaccine series and reduce missed opportunities to vaccinate in rural primary care practices.
Carney PA; Hatch B; Stock I; Dickinson C; Davis M; Larsen R; Valenzuela S; Marino M; Darden PM; Gunn R; Ferrara L; Fagnan LJ
Implement Sci; 2019 Mar; 14(1):30. PubMed ID: 30866981
[TBL] [Abstract][Full Text] [Related]
27. Pharmacist insights into adolescent human papillomavirus vaccination provision in the United States.
Islam JY; Gruber JF; Kepka D; Kunwar M; Smith SB; Rothholz MC; Brewer NT; Smith JS
Hum Vaccin Immunother; 2019; 15(7-8):1839-1850. PubMed ID: 30550369
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus vaccination of females in a large health claims database in the United States, 2006-2012.
Dunne EF; Stokley S; Chen W; Zhou F
J Adolesc Health; 2015 Apr; 56(4):408-13. PubMed ID: 25797632
[TBL] [Abstract][Full Text] [Related]
29. Predictors of Human Papillomavirus Vaccine Completion Among Low-Income Latina/o Adolescents.
Gerend MA; Stephens YP; Kazmer MM; Slate EH; Reyes E
J Adolesc Health; 2019 Jun; 64(6):753-762. PubMed ID: 30777636
[TBL] [Abstract][Full Text] [Related]
30. Parents Who Decline HPV Vaccination: Who Later Accepts and Why?
Kornides ML; McRee AL; Gilkey MB
Acad Pediatr; 2018 Mar; 18(2S):S37-S43. PubMed ID: 29502636
[TBL] [Abstract][Full Text] [Related]
31. Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls.
Lindley MC; Jeyarajah J; Yankey D; Curtis CR; Markowitz LE; Stokley S
Hum Vaccin Immunother; 2016 Jun; 12(6):1519-27. PubMed ID: 27003108
[TBL] [Abstract][Full Text] [Related]
32. Success of an EMR-Driven Postpartum Intervention to Improve HPV Vaccination Rates.
Park SK; Holschneider CH; Chen J; Saleeby E; Singhal R
J Community Health; 2020 Jun; 45(3):446-451. PubMed ID: 31659600
[TBL] [Abstract][Full Text] [Related]
33. Improving HPV Vaccination Rates Using Maintenance-of-Certification Requirements.
Fiks AG; Luan X; Mayne SL
Pediatrics; 2016 Mar; 137(3):e20150675. PubMed ID: 26908681
[TBL] [Abstract][Full Text] [Related]
34. Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program.
Faisal-Cury A; Levy RB; Tourinho MF; Grangeiro A; Eluf-Neto J
BMC Public Health; 2020 Apr; 20(1):458. PubMed ID: 32252705
[TBL] [Abstract][Full Text] [Related]
35. Provider Experience Recommending HPV Vaccination Before Age 11 Years.
Biancarelli DL; Drainoni ML; Perkins RB
J Pediatr; 2020 Feb; 217():92-97. PubMed ID: 31757474
[TBL] [Abstract][Full Text] [Related]
36. An innovative housing-related measure for individual socioeconomic status and human papillomavirus vaccination coverage: A population-based cross-sectional study.
MacLaughlin KL; Jacobson RM; Sauver JLS; Jacobson DJ; Fan C; Wi CI; Finney Rutten LJ
Vaccine; 2020 Sep; 38(39):6112-6119. PubMed ID: 32713679
[TBL] [Abstract][Full Text] [Related]
37. Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents.
Hansen BT; Campbell S; Burger E; Nygård M
Prev Med; 2015 Aug; 77():4-10. PubMed ID: 25944266
[TBL] [Abstract][Full Text] [Related]
38. Theory-based development of an implementation intervention to increase HPV vaccination in pediatric primary care practices.
Garbutt JM; Dodd S; Walling E; Lee AA; Kulka K; Lobb R
Implement Sci; 2018 Mar; 13(1):45. PubMed ID: 29534761
[TBL] [Abstract][Full Text] [Related]
39. Implementation of HPV vaccination guidelines in a diverse population in Los Angeles: Results from an environmental scan of local HPV resources and needs.
Baezconde-Garbanati L; Lienemann BA; Robles M; Johnson E; Sanchez K; Singhal R; Steinberg J; Jaque JM; Pentz MA; Gruber S
Vaccine; 2017 Sep; 35(37):4930-4935. PubMed ID: 28774559
[TBL] [Abstract][Full Text] [Related]
40. Enrolling a rural community pharmacy as a Vaccines for Children provider to increase HPV vaccination: a feasibility study.
Daniel CL; Lawson F; Vickers M; Green C; Wright A; Coyne-Beasley T; Lee HY; Turberville S
BMC Public Health; 2021 Jun; 21(1):1266. PubMed ID: 34187438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
